Predictions
Alpha Pro Tech Ltd.
Start price
Target price
Perf. (%)
€6.22
11.07.21
11.07.21
€12.00
11.07.22
11.07.22
-30.03%
12.07.22
12.07.22
Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
Small cyclical dependencies
Undervalued
CareCloud Inc.
Start price
Target price
Perf. (%)
€6.85
10.07.21
10.07.21
€3.20
10.07.22
10.07.22
-46.86%
11.07.22
11.07.22
Growths slower than the competition
Below average Marketposition
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Eckert & Ziegler BEBIG SA
Start price
Target price
Perf. (%)
-
14.09.21
14.09.21
€137.00
14.09.22
14.09.22
-
10.07.22
10.07.22
Could be worthwhile Investment >10% per year
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€348.40
08.07.21
08.07.21
-
08.07.22
08.07.22
44.86%
08.07.22
08.07.22
Thermo Fisher Scientific Inc.
Start price
Target price
Perf. (%)
€439.20
08.07.21
08.07.21
-
08.07.22
08.07.22
23.13%
08.07.22
08.07.22
Medtronic plc
Start price
Target price
Perf. (%)
€107.60
08.07.21
08.07.21
€130.00
08.07.22
08.07.22
-18.17%
08.07.22
08.07.22
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€43.94
08.07.21
08.07.21
€55.00
08.07.22
08.07.22
-34.74%
08.07.22
08.07.22
Drägerwerk AG & Co. KGaA ST
Start price
Target price
Perf. (%)
€77.90
08.07.21
08.07.21
-
08.07.22
08.07.22
-46.53%
08.07.22
08.07.22
Veeva Systems A
Start price
Target price
Perf. (%)
€269.00
29.06.21
29.06.21
€275.00
29.06.22
29.06.22
-29.38%
29.06.22
29.06.22
Top 10 in its market
Could be worthwhile Investment >10% per year
Innovative
Some uniques
Anthem Inc.
Start price
Target price
Perf. (%)
€363.90
20.10.21
20.10.21
€400.00
31.12.23
31.12.23
26.90%
28.06.22
28.06.22
Could be very worthwhile Investment >20% year
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€373.45
20.10.21
20.10.21
€450.00
31.12.23
31.12.23
28.49%
28.06.22
28.06.22
Could be very worthwhile Investment >20% year
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€2.24
24.06.22
24.06.22
€5.00
24.06.23
24.06.23
-1.57%
26.06.22
26.06.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group